跳至主要内容
临床试验/EUCTR2007-005534-36-GB
EUCTR2007-005534-36-GB进行中(未招募)不适用

The effect of Exenatide on satiety, metabolic parameters and regional brain activation in response to nutrient ingestion in Type 2 diabetes.

King's College Hospital0 个研究点目标入组 60 人开始时间: 2007年12月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • People with Type 2 diabetes:
  • 1. 18-65 years of age
  • 2. Type 2 diabetes, with evidence of residual insulin secretion and insulin resistance as determined by absence of requirement for insulin therapy
  • 3. HbA1c (gold standard blood glucose control measure) 5.5-9.0%
  • 4. Diabetes controlled by either diet and exercise +/- combination of oral hypoglycaemic therapy (Metformin, Sulphonylurea, Meteglinides and/or thiazolidinediones.
  • 5. Diabetes therapy unchanged for three months prior to the study
  • 6. Clear understanding of written and spoken English
  • 7. Ability to given written consent
  • Healthy volunteers (subjects without diabetes for generation of normative data with this scanning protocol):18-65 years of age with no significant medical history and not taking regular medications, who have a clear understanding of written and spoken English and are able to given written consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Uncontrolled hypertension (blood pressure)
  • 2. Unstable diabetes control as judged by the investigator
  • 3. Insulin treated diabetes
  • 4. Cardiac failure (NYHA Grade 2 or higher - objective measure of heart failure)
  • 5. Inabililty fully to comprehend verbal and written English/understand the protocol
  • 6. Left handed subjects
  • 7. Weight >120kg.
  • 8. Contraindictation to fMRI scanning (metal implants; shrapnel injuries; cardiac pacemaker; claustrophobia)
  • 9. Subjects who suffer from claustrophobia
  • 10. Needle phobic subjects
  • 11. Patients taking recreational drugs
  • 12. Patients who have received any investigational drugs in the past 3 months.
  • 13. Pregnant females or those actively trying to become pregnant
  • 14. Subjects at high risk or with blood bourne infectious disease, such as HIV, Hepatitis B/C.

研究者

相似试验